“Real-World Data on the Incidence of Immune-Related Adverse Events Associated With Anti-PD-1 PD-L1 Treatment in Russia”. Voprosy onkologii 68, no. 2 (May 6, 2022): 188–199. Accessed October 14, 2026. https://voprosyonkologii.ru/index.php/journal/article/view/1378.